eli lilly glp 1 drug FDA approves new weight-loss pill, Foundayo Eli Lilly Weight-Loss Pill Shows

Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition

For food and beverage companies, understanding how their use might evolve will be critical to staying relevant, from reformulating products to meeting new nutritional needs

Find the Best Option for Your Weight Management Goals.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been studied for their cardiovascular benefits in type 2 diabetes

Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work

More on, ADA and AACE Guidelines prefer GLP1RA over DPP4i for patients with established ASCVD or indicato...